Semler Scientific to Report Second Quarter and First Half of 2024 Financial Results and Host Conference Call on August 5, 2024

Semler Scientific (Nasdaq: SMLR), a company focused on developing technology solutions for chronic disease management in healthcare, has announced its plans to report financial results for Q2 and H1 2024 on August 5, 2024, after U.S. market close.

Rhea-AI Summary

Semler Scientific (Nasdaq: SMLR), a company focused on developing technology solutions for chronic disease management in healthcare, has announced its plans to report financial results for Q2 and H1 2024 on August 5, 2024, after U.S. market close. The company will host a conference call at 4:30 pm ET on the same day, led by CEO Doug Murphy-Chutorian, with participation from Chairman Eric Semler, CFO Renae Cormier, and COO Jennifer Oliva-Herrington.

Investors are encouraged to submit questions in advance to ir@semlerscientific.com and pre-register for the call. Those unable to pre-register can dial in using provided domestic and international numbers. The call will be archived on Semler Scientific's website for future reference.

Argus Session date unavailable

-0.73% session move Open Argus

Details

News Market Reaction – SMLR

The recorded move for SMLR in the trading session of this news was -0.73%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SANTA CLARA, Calif., July 22, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced that it will report financial results for the second quarter and six months ended June 30, 2024, after the close of U.S. financial markets on Monday, August 5, 2024. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Eric Semler, chairman, Renae Cormier, chief financial officer, and Jennifer Oliva-Herrington, chief operating officer, will join him on the call. Please submit questions prior to the start of the call to ir@semlerscientific.com. 

We encourage participants to pre-register for the conference call using the following link: https://dpregister.com/sreg/10190580/fcfdde76dc. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.

Those without internet access or unable to pre-register may dial in by calling:
Domestic callers: 833-816-1161
International callers: 412-317-0717

Please specify to the operator that you would like to join the "Semler Scientific Call." The conference call will be archived on Semler Scientific's website at www.semlerscientific.com. 

About Semler Scientific, Inc.:
Semler Scientific, Inc. develops, manufactures and markets innovative products and services to combat chronic diseases. Its flagship product, QuantaFlo^®, which is patented and cleared by the U.S. Food and Drug Administration (FDA), is a rapid point-of-care test that measures arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of cardiovascular diseases, such as peripheral arterial disease (PAD), and Semler Scientific is seeking a new 510(k) clearance for expanded-indications. QuantaFlo is used by healthcare providers to evaluate their patient's risk of mortality and major adverse cardiovascular events (MACE). Semler Scientific also invests in bitcoin and has adopted bitcoin as its primary treasury asset. Additional information about Semler Scientific can be found at www.semlerscientific.com.

CONTACT:

Renae Cormier, CFO
ir@semlerscientific.com  

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/semler-scientific-to-report-second-quarter-and-first-half-of-2024-financial-results-and-host-conference-call-on-august-5-2024-302203104.html

SOURCE Semler Scientific, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Semler Scientific (SMLR) report its Q2 and H1 2024 financial results?

Semler Scientific (SMLR) will report its Q2 and H1 2024 financial results on August 5, 2024, after the close of U.S. financial markets.

What time is Semler Scientific's (SMLR) Q2 2024 earnings conference call scheduled for?

Semler Scientific's (SMLR) Q2 2024 earnings conference call is scheduled for 4:30 pm ET on August 5, 2024.

Who will be hosting Semler Scientific's (SMLR) Q2 2024 earnings call?

Semler Scientific's (SMLR) Q2 2024 earnings call will be hosted by CEO Doug Murphy-Chutorian, with participation from Chairman Eric Semler, CFO Renae Cormier, and COO Jennifer Oliva-Herrington.

How can investors submit questions for Semler Scientific's (SMLR) Q2 2024 earnings call?

Investors can submit questions for Semler Scientific's (SMLR) Q2 2024 earnings call by emailing ir@semlerscientific.com prior to the start of the call.